Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dorothea Horvath"'
Autor:
Jens C. Eickhoff, George Wilding, Mary Jane Staab, Miroslav Malkovsky, Douglas G. McNeel, Mahazarin R. Kaikobad, Dorothea Horvath, Joshua M. Lang, Marianne Wallace, Glenn Liu
Publikováno v:
Cancer immunology, immunotherapy : CII. 60(10)
Prior to the advent of VEGF-targeted therapies, renal cell carcinoma (RCC) was among the few solid tumors shown to respond to cytokine-based therapies such as interleukin-2 (IL-2) and interferon alpha. Previous work has shown that aminobisphosphonate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd099efc3b153b207d285be16b2a329f
https://pubmed.ncbi.nlm.nih.gov/21647691
https://pubmed.ncbi.nlm.nih.gov/21647691
Autor:
Dorothea Horvath, George Wilding, Thomas Frye, Glenn Liu, James G. Davies, Jens C. Eickhoff, Douglas G. McNeel, Dona Alberti, Rebecca Marnocha, Jane Straus, Mary Jane Staab, Edward J. Dunphy, Laura E. Johnson
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(25)
PurposeProstatic acid phosphatase (PAP) is a prostate tumor antigen. We have previously demonstrated that a DNA vaccine encoding PAP can elicit antigen-specific CD8+ T cells in rodents. We report here the results of a phase I/IIa trial conducted with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd5fb2350663a1c8c0f12a483d2076e
https://pubmed.ncbi.nlm.nih.gov/20008614
https://pubmed.ncbi.nlm.nih.gov/20008614
Autor:
C. Sidor, Antliofiy Treston, Mary Jane Staab, Constantin T. Yiannoutsos, Glenn Liu, Karen Fife, Dorothea Horvath, Christopher Sweeney, Victoria Armstrong, Jill M. Kolesar, George Wilding
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 11(18)
Purpose: To determine whether the preclinical antitumor and antiangiogenic activity of 2-methoxyestradiol can be translated to the clinic. Experimental Design: Men with hormone-refractory prostate cancer were enrolled into this phase II randomized, d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2245742a5c8491491a4b023fb4b91baa
https://pubmed.ncbi.nlm.nih.gov/16166441
https://pubmed.ncbi.nlm.nih.gov/16166441
Autor:
Emily Robinson, Lynn Van Ummersen, Kurt R. Oettel, George Wilding, Dorothea Horvath, David L. DeMets, Kendra D. Tutsch, Rhoda Z. Arzoomanian, James McGovern, Hamied Rezazadeh, Glenn Liu, Dona Alberti, Howard H. Bailey, Mary Jane Staab
Publikováno v:
Investigational new drugs. 21(3)
Objective. We conducted a phase II multicenter trial of perillyl alcohol in patients with advanced hormone refractory prostate cancer (HRPC). The primary endpoint was to evaluate the 6-month progression-free survival given the potential cytostatic na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a670c8d6efc19bdbdf3907e03cdb96cc
https://pubmed.ncbi.nlm.nih.gov/14578686
https://pubmed.ncbi.nlm.nih.gov/14578686
Autor:
Glenn, Liu, Kurt, Oettel, Gregory, Ripple, Mary Jane, Staab, Dorothea, Horvath, Dona, Alberti, Rhoda, Arzoomanian, Rebecca, Marnocha, Reginald, Bruskewitz, Richard, Mazess, Charles, Bishop, Abhik, Bhattacharya, Howard, Bailey, George, Wilding
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(9)
This Phase I study of 1alpha-hydroxyvitamin D(2), an p.o. administered vitamin D analogue, in patients with advanced hormone-refractory prostate cancer was designed to assess the toxicity, pharmacokinetic and biological markers of drug activity, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::717bfd2c5699eab902373cec23fbf5df
https://pubmed.ncbi.nlm.nih.gov/12231522
https://pubmed.ncbi.nlm.nih.gov/12231522